Arcus Biosciences, Inc.RCUSNYSE
Loading
Debt to Equity Over TimeElevated
Percentile Rank89
3Y CAGR-4.9%
5Y CAGR+34.2%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-4.9%/yr
Annual compound
5Y CAGR
+34.2%/yr
Recent deceleration
Percentile
P89
Within normal range
vs 5Y Ago
4.4x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.16 | +26.8% |
| 2024 | 0.12 | +419.6% |
| 2023 | 0.02 | -87.0% |
| 2022 | 0.18 | +26.0% |
| 2021 | 0.14 | +302.1% |
| 2020 | 0.04 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |